News
ENOV
26.50
+0.68%
0.18
Weekly Report: what happened at ENOV last week (0413-0417)?
Weekly Report · 8h ago
Analyst Backs Enovis On Cash Flow Turnaround
Benzinga · 3d ago
Enovis: Discounted Valuation With Clear Free Cash Flow Upside and Product Catalysts Support Buy Rating
TipRanks · 3d ago
Enovis assumed with an Outperform at William Blair
TipRanks · 3d ago
Is It Time To Reconsider Enovis (ENOV) After Recent Share Price Rebound
Simply Wall St · 5d ago
Enovis price target lowered to $39 from $43 at BTIG
TipRanks · 04/13 11:52
BTIG Sticks to Its Buy Rating for Enovis (ENOV)
TipRanks · 04/13 11:38
Weekly Report: what happened at ENOV last week (0406-0410)?
Weekly Report · 04/13 10:28
A Look At Enovis (ENOV) Valuation After Recent Share Price Rebound From A Weaker Year
Simply Wall St · 04/11 03:28
Enovis to Host First Quarter 2026 Results Conference Call on May 7th
Barchart · 04/10 07:00
Enovis Is Maintained at Outperform by Evercore ISI Group
Dow Jones · 04/06 17:17
Evercore ISI Group Maintains Outperform on Enovis, Lowers Price Target to $35
Benzinga · 04/06 17:07
Weekly Report: what happened at ENOV last week (0330-0403)?
Weekly Report · 04/06 10:28
3 Healthcare Stocks with Open Questions
Barchart · 04/02 01:34
Weekly Report: what happened at ENOV last week (0323-0327)?
Weekly Report · 03/30 10:28
Enovis, Neogen, Humana, LifeStance Health Group, and Hims & Hers Health Stocks Trade Down, What You Need To Know
Barchart · 03/27 13:16
Weekly Report: what happened at ENOV last week (0316-0320)?
Weekly Report · 03/23 10:25
Wells Fargo Sticks to Its Buy Rating for Enovis (ENOV)
TipRanks · 03/18 10:35
Enovis assumed with an Overweight at Wells Fargo
TipRanks · 03/18 10:30
Weekly Report: what happened at ENOV last week (0309-0313)?
Weekly Report · 03/16 10:24
More
Webull provides a variety of real-time ENOV stock news. You can receive the latest news about Enovis Corp through multiple platforms. This information may help you make smarter investment decisions.
About ENOV
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).